Target Price | $739.50 |
Price | $795.48 |
Deviation | 7.04% |
Number of Estimates | 16 |
16 Analysts have issued a price target Axon Enterprise Inc 2026 . The average Axon Enterprise Inc target price is $739.50. This is 7.04% lower than the current stock price. The highest price target is $939.75 18.14% , the lowest is $585.11 26.45% . | |
A rating was issued by 23 analysts: 19 Analysts recommend Axon Enterprise Inc to buy, 4 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Axon Enterprise Inc stock has an average upside potential 2026 of 7.04% . Most analysts recommend the Axon Enterprise Inc stock at Purchase. |
18 Analysts have issued a sales forecast Axon Enterprise Inc 2025 . The average Axon Enterprise Inc sales estimate is $2.7b . This is 0.89% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $2.8b 4.95% , the lowest is $2.6b 4.14% .
This results in the following potential growth metrics:
2024 | $2.1b | 33.21% |
---|---|---|
2025 | $2.7b | 30.13% |
2026 | $3.3b | 22.80% |
2027 | $4.0b | 18.69% |
18 Analysts have issued an Axon Enterprise Inc EBITDA forecast 2025. The average Axon Enterprise Inc EBITDA estimate is $684m . This is 517.73% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $726m 555.31% , the lowest is $648m 484.85% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $112m | 40.42% |
---|---|---|
2025 | $684m | 512.70% |
2026 | $867m | 26.74% |
2027 | $1.1b | 31.93% |
2024 | 5.36% | 55.27% |
---|---|---|
2025 | 25.25% | 370.89% |
2026 | 26.06% | 3.21% |
2027 | 28.96% | 11.13% |
19 Axon Enterprise Inc Analysts have issued a net profit forecast 2025. The average Axon Enterprise Inc net profit estimate is $491m . This is 5.68% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $607m 30.61% , the lowest is $410m 11.90% .
This results in the following potential growth metrics and future Net Margins:
2024 | $377m | 116.40% |
---|---|---|
2025 | $491m | 30.34% |
2026 | $609m | 24.00% |
2027 | $714m | 17.19% |
2024 | 18.10% | 62.45% |
---|---|---|
2025 | 18.13% | 0.14% |
2026 | 18.31% | 0.99% |
2027 | 18.08% | 1.26% |
19 Analysts have issued a Axon Enterprise Inc forecast for earnings per share. The average Axon Enterprise Inc EPS is $6.31 . This is 10.70% higher than earnings per share in the financial year 2024. The highest EPS forecast is $7.80 36.84% , the lowest is $5.26 7.72% .
This results in the following potential growth metrics and future valuations:
2024 | $4.80 | 107.79% |
---|---|---|
2025 | $6.31 | 31.46% |
2026 | $7.83 | 24.09% |
2027 | $9.17 | 17.11% |
Current | 139.56 | 62.21% |
---|---|---|
2025 | 126.02 | 9.70% |
2026 | 101.63 | 19.35% |
2027 | 86.73 | 14.66% |
Based on analysts' sales estimates for 2025, the Axon Enterprise Inc stock is valued at an EV/Sales of 22.72 and an P/S ratio of 22.85 .
This results in the following potential growth metrics and future valuations:
Current | 22.92 | 76.58% |
---|---|---|
2025 | 22.72 | 0.88% |
2026 | 18.50 | 18.57% |
2027 | 15.59 | 15.75% |
Current | 23.05 | 74.54% |
---|---|---|
2025 | 22.85 | 0.88% |
2026 | 18.61 | 18.57% |
2027 | 15.68 | 15.75% |
Axon Enterprise Inc...
Analyst | Rating | Action | Date |
---|---|---|---|
B of A Securities |
Buy
➜
Buy
|
Unchanged | Jun 04 2025 |
Goldman Sachs |
Buy
➜
Buy
|
Unchanged | May 14 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | May 09 2025 |
Needham |
Buy
➜
Buy
|
Unchanged | May 08 2025 |
Needham |
Buy
➜
Buy
|
Unchanged | Apr 23 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Feb 27 2025 |
Citizens Capital Markets |
Market Outperform
➜
Market Outperform
|
Unchanged | Feb 26 2025 |
Analyst Rating | Date |
---|---|
Unchanged
B of A Securities:
Buy
➜
Buy
|
Jun 04 2025 |
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
May 14 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
May 09 2025 |
Unchanged
Needham:
Buy
➜
Buy
|
May 08 2025 |
Unchanged
Needham:
Buy
➜
Buy
|
Apr 23 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Feb 27 2025 |
Unchanged
Citizens Capital Markets:
Market Outperform
➜
Market Outperform
|
Feb 26 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.